EGLN1 and lung carcinoma: Based on lung adenocarcinoma (LUAD) data extracted from the Cancer Genome Atlas (TCGA) database, we found that PHD2 expression was higher in lung cancer tissues than in adjacent normal tissues (Figure 1A), indicating an essential role of PHD2 in non-small cell lung cancer (NSCLC).